Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin

Blood. 1991 Feb 15;77(4):906.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • ABO Blood-Group System*
  • Adult
  • Blood Group Incompatibility / complications*
  • Bone Marrow Transplantation*
  • Erythropoietin / therapeutic use*
  • Humans
  • Male
  • Recombinant Proteins / therapeutic use
  • Red-Cell Aplasia, Pure / drug therapy*
  • Red-Cell Aplasia, Pure / etiology

Substances

  • ABO Blood-Group System
  • Recombinant Proteins
  • Erythropoietin